Synthetic demonstration

A cleaner dossier before regulatory review.

This fictitious example shows how NaruDesk organises documents, versions, missing information and open questions before a Korean cosmetic dossier reaches an EU Responsible Person or qualified safety assessor.

A4 PDF · English · 5 pages · no real client data

One intake view. Four working layers.

The sample is designed for a partner conversation. It shows the preparation format, not a fabricated regulatory approval.

  1. 01

    Document register

    Files received, version dates, status and the next owner.

  2. 02

    Cross-document gaps

    Name, fill volume, formula version, claims and artwork questions.

  3. 03

    Action list

    One owner, one requested item and one target date per line.

  4. 04

    Handoff summary

    What is ready, what remains open and how confidential data moves.

The work is coordination, not a verdict.

Every item is framed as an observed fact, gap, question or human decision.

FACT

The product brief and artwork use two different commercial names.

Owner: Brand
GAP

The pack specification states 32 mL while the artwork states 30 mL.

Owner: Manufacturer
QUESTION

Which formula version was covered by the latest stability summary?

Owner: Manufacturer + lab
HUMAN

The draft EU artwork still contains a placeholder RP address.

Owner: EU RP

What this sample does not claim.

It does not determine compliance, perform a safety assessment, approve a formula, claim or label, submit a CPNP notification, act as the Responsible Person or provide legal advice.

The quantitative formula and underlying confidential data move directly to the EU RP or qualified safety assessor through the partner-approved route.

Reference points: Regulation (EC) No 1223/2009, Commission Regulation (EU) No 655/2013 and the European Commission CPNP information page. Sources accessed 28 July 2026 and listed in the PDF.

Does this fit your intake process?

I am looking for one or two EU Responsible Person or safety-assessor partners. I handle the Korean-side preparation and follow-up. Your team retains every regulatory and safety decision.

[email protected]